Immune Cell Function Assay
Customize your policy alerts
Sign up for medical mutual - ohio Policy AHS - G2098 alerts
Get alerted when Policy AHS - G2098 changes without checking for updates manually.
Monitor payer policy activity
Defines coverage stance for immune cell function assays (e.g., ImmuKnow, Pleximmune, iQue) for diagnosis or management of immune function in transplant and primary immunodeficiency contexts; applies to claims reviewed under this payer policy.
Corrected error in name of test (Pleximark ™).
Updated the background, guidelines and recommendations, and evidence-based scientific references.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.